Provided by Tiger Trade Technology Pte. Ltd.

Heron Therapeutics

0.3559
+0.042413.52%
Post-market: 0.3440-0.0119-3.34%19:39 EDT
Volume:3.18M
Turnover:1.09M
Market Cap:67.27M
PE:-1.93
High:0.3599
Open:0.3151
Low:0.3129
Close:0.3135
52wk High:1.58
52wk Low:0.2610
Shares:189.00M
Float Shares:147.00M
Volume Ratio:1.68
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1842
EPS(LYR):-0.1211
ROE:-2408.88%
ROA:-2.80%
PB:11.48
PE(LYR):-2.94

Loading ...

Heron Therapeutics downgraded to Hold from Buy at Needham

TIPRANKS
·
Jun 03

Sector Update: Healthcare Stocks Fall in Afternoon Trading

MT Newswires Live
·
Jun 03

Heron announces U.S. district court decision regarding Cinvanti patents

TIPRANKS
·
Jun 02

Heron Therapeutics Says US Court Rules 2 Cinvanti Patent Claims 'Invalid'

MT Newswires Live
·
Jun 02

BRIEF-U.S. District Court Issues Decision Regarding CINVANTI Patents

Reuters
·
Jun 02

Heron Therapeutics - Decision Does Not Impact Prior Settlements Related to Cinvanti or Aponvie

THOMSON REUTERS
·
Jun 02

U.S. District Court Issues Decision Regarding Cinvanti® Patents

THOMSON REUTERS
·
Jun 02

Heron Therapeutics - to Appeal Patent Decision to Federal Circuit Court

THOMSON REUTERS
·
Jun 02

Heron Therapeutics - U.S. Court Rules Asserted Claims of Heron's Cinvanti Patents Invalid

THOMSON REUTERS
·
Jun 02

Delaware court invalidates Heron Cinvanti patent claims in Azurity litigation

Reuters
·
Jun 02

Heron Therapeutics Faces Tight Covenant Constraints That Threaten Liquidity and Strategic Flexibility

TIPRANKS
·
May 12

Heron Therapeutics Signals Recovery Despite Soft Q1

TIPRANKS
·
May 12

Analysts’ Opinions Are Mixed on These Healthcare Stocks: ALX Oncology Holdings (ALXO) and Heron Therapeutics (HRTX)

TIPRANKS
·
May 12

Heron Therapeutics price target lowered to $4 from $6 at H.C. Wainwright

TIPRANKS
·
May 12

Heron Therapeutics backs FY26 revenue view $173M-$183M, consensus $174.73M

TIPRANKS
·
May 12

Heron Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 11

Heron Therapeutics' Q1 revenue falls as oncology sales drop

Reuters
·
May 11

Heron Therapeutics Q1 EPS $(0.04) Misses $(0.03) Estimate, Sales $34.711M Miss $38.350M Estimate

Benzinga Earnings
·
May 11

BRIEF-Heron Therapeutics Q1 EPS USD -0.04

Reuters
·
May 11

Heron Therapeutics Inc: Reaffirmed 2026 Full-Year Guidance of $173-$183 Mln Net Revenue

THOMSON REUTERS
·
May 11